Age (years), cohorts | |||||||
18–22 | 23–27 | 28–32 | 33–37 | 38–42 | 43–65 | All | |
Number of patients (%) | 20 (25) | 13 (16) | 10 (13) | 14 (18) | 9 (11) | 13 (16) | 79 |
Age, years | 20.4±1.3 | 25.7±1.8 | 31.3±1.5 | 35.2±1.5 | 41.1±1.1 | 50.8±7.6 | 32.6±11.0 |
BMI, kg/m2 | 20.9±2.5 | 21.5±4.4 | 21.8±3.9 | 22.4±3.0 | 21.9±1.7 | 21.9±1.9 | 21.7±3.0 |
PI, N | 15 | 8 | 9 | 6 | 5 | 6 | 49 |
FEV1, L | 2.7±0.8 | 2.3±0.7 | 2.4±0.8 | 2.3±0.9 | 1.9±1.0 | 1.7±0.7 | 2.3±0.9 |
FEV1% of predicted | 78±23 | 66±19 | 74±23 | 71±24 | 58±27 | 60±19 | 69±23 |
FVC, L | 3.8±0.7 | 3.3±0.5 | 3.7±0.8 | 3.4±0.7 | 3.1±0.9 | 2.8±0.7 | 3.4±0.8 |
FVC% of predicted | 93±16 | 82±11 | 94±16 | 88±15 | 79±19 | 81±14 | 87±16 |
FEV1/FVC % | 72±14 | 69±15 | 66±12 | 64±14 | 58±14 | 58±12 | 65±14 |
MVV, L min−1 | 110±28 | 97±28 | 106±30 | 102±34 | 78±37 | 81±29 | 97±32 |
Data are presented as mean±SD or N (%).
BMI, body mass index; FEV1, forced expiratory volume after 1 s; FVC, forced vital capacity; PI, exocrine pancreas insufficiency.